Bicycle Therapeutics(BCYC)

20.21 0.63 3.2176%

今开:19.53昨收:19.58
最高:20.5399 最低:19.27
涨停价:0.0跌停价:0.0
总市值:1.391985152E9

Bicycle Therapeutics的热门讨论

产业链观察05-23 21:27

#药闻简讯# $Bicycle Therapeutics(BCYC)$ 宣布5.55亿美元私募股权融资查看全文

其他

Bicycle Therapeutics(BCYC)04-18 19:05

$Bicycle Therapeutics(BCYC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-048578  Act: 34  Size: 164 KB 网页链接查看全文

首次持股声明

Bicycle Therapeutics(BCYC)04-18 19:35

$Bicycle Therapeutics(BCYC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-045304  Size: 20 KB 网页链接查看全文

持股变动声明

Bicycle Therapeutics(BCYC)04-23 04:05

$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046415  Size: 27 KB 网页链接查看全文

超过5%股东持股披露「修订」

Bicycle Therapeutics(BCYC)05-29 04:35

$Bicycle Therapeutics(BCYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-065602  Act: 34  Size: 109 KB 网页链接查看全文

超过5%股东持股披露

Bicycle Therapeutics(BCYC)06-08 04:25

$Bicycle Therapeutics(BCYC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-069660  Act: 34  Size: 91 KB 网页链接查看全文

证券出售报告

Bicycle Therapeutics(BCYC)07-04 01:25

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000169  Act: 33  Size: 4 KB 网页链接查看全文

当期报告

Bicycle Therapeutics(BCYC)05-02 19:15

$Bicycle Therapeutics(BCYC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-055981  Act: 34  Size: 305 KB 网页链接查看全文

季度财报

Bicycle Therapeutics(BCYC)05-02 19:25

$Bicycle Therapeutics(BCYC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-006453  Act: 34  Size: 9 MB 网页链接查看全文

其他

Bicycle Therapeutics(BCYC)04-16 04:15

$Bicycle Therapeutics(BCYC)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-047270  Act: 34  Size: 8 MB 网页链接查看全文

1 2 3

Bicycle Therapeutics的最新讨论

chuminhua2021-10-08 15:53

10月7日,Bicycle Therapeutics公司今日宣布,两款新一代双环肽偶联毒素在1期临床试验中显示积极抗癌活性。其中,靶向EphA2的双环肽偶联毒素BT5528让两名接受治疗的尿路上皮癌患者均获得部分缓解,在卵巢癌患者中达到80%的疾病控制率。
BT5528是一款靶向EphA2的双环肽偶联毒素。EphA2在多种难...查看全文

牛唐2021-10-08 10:23

医药板块速评(2021.10.07)
本期内容提示:
1、RLAY数据在即,如何看待AI选药概念股?
2、ALLO的实验被叫停,对基因编辑板块影响如何?
3、第一大仓位BCYC数据不错,已实现150%+的收益,谁是下一个BCYC?
$Relay Therapeutics(RLAY)$ $Intellia(NTLA)$ $Bicycle治疗(BCYC)$查看全文

美股马甲2021-10-06 07:19

$Bicycle治疗(BCYC)$ 听说这周要开彩票了查看全文

Takeabreak2021-09-02 06:37

$Bicycle治疗(BCYC)$ 前方开拓出了一片新天地,少有的量。自行车是慢了点,好在比汽车安全[笑]目标100查看全文

Takeabreak2021-07-20 11:21

$Bicycle治疗(BCYC)$ 这两天少数欣慰的票之一。价上了,量也配合查看全文

产业链观察2021-07-14 16:46

药闻| 2021年7月13日,基于其专有的双环肽 ( Bicycle® ) 技术开创了一种新型差异化疗法的生物技术公司$Bicycle治疗(BCYC)$ )宣布Ionis Pharmaceuticals 已行使其选择权并签订了一项全球独家许可和合作协议,使用对转铁蛋白受体 (TfR1) 具有高亲和力的双环肽进行寡核苷酸治疗(#RNAi疗...查看全文

chuminhua2021-07-14 11:40

7月13日,生物技术公司Bicycle Therapeutics plc(纳斯达克:BCYC),在其专利的双环肽(Bicycle®)技术的基础上开创了一种新的、差异化的治疗方法,今天宣布,Ionis制药公司已行使其选择权,并签订了独家的全球许可和合作协议, 使用与转铁蛋白受体 (TfR1) 具有高亲和力的 Bicycle:reg...查看全文

Takeabreak2021-05-11 23:46

$Bicycle治疗(BCYC)$ BCYC Bicycle Therapeutics price target raised to $44 from $38 at Oppenheimer查看全文

Takeabreak2021-03-12 11:25

$Bicycle治疗(BCYC)$ 重起升势,会前先看30
网页链接{Bicycle Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference | Bic...查看全文

PDC药物的时间窗口或许就是现在?

丰硕创投2021-03-12 10:23

2763字3图,阅读大约需要6分钟。
文章首发于丰硕创投,欢迎朋友圈与微信转发。
公众号及其它平台转载请后台留言。
PDC药物正处于ADC药物当年起飞的时间节点上,但市场还未认识到它的价值,PDC能否引爆偶联药物,让我们拭目以待。
1.PDC药物简介
2.竞争格局
3.PDC药物临床...查看全文

1 2 3 4 5 6

Bicycle Therapeutics的公告

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000168  Act: 33  Size: 4 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000169  Act: 33  Size: 4 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000170  Act: 33  Size: 5 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000164  Act: 33  Size: 4 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000165  Act: 33  Size: 4 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000166  Act: 33  Size: 4 KB 网页链接

证券出售报告

$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000167  Act: 33  Size: 4 KB 网页链接

持股变动声明

$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075569  Size: 29 KB 网页链接

发行公告

$Bicycle Therapeutics(BCYC)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001761612-24-000003  Act: 33  Size: 20 KB 网页链接

超过5%股东持股披露

$Bicycle Therapeutics(BCYC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-069660  Act: 34  Size: 91 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47